-
Entity
-
Individual
-
Location
-
C/O Cerevel Therapeutics Holdings, Inc., 131 Dartmouth Street Suite 502, Boston, Massachusetts
-
Summary
-
The estimated net worth of Kathleen Tregoning is at least $3.07 M dollars as of May 30, 2024. Kathleen Tregoning is the Title: Chief Corporate Affairs Officer of Cerevel Therapeutics Holdings, Inc. and owns shares of Cerevel Therapeutics Holdings, Inc. (CERE) stock worth about $2.95 M. Kathleen Tregoning is the Director of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $120 K.